4//SEC Filing
MANNING JOSEPH J 4
Accession 0001415889-21-000529
CIK 0000001800other
Filed
Feb 2, 7:00 PM ET
Accepted
Feb 3, 7:20 PM ET
Size
10.9 KB
Accession
0001415889-21-000529
Insider Transaction Report
Form 4
MANNING JOSEPH J
Senior Vice President
Transactions
- Exercise/Conversion
Common shares without par value
2021-02-01$38.40/sh+18,750$720,000→ 81,561 total - Sale
Common shares without par value
2021-02-01$122.79/sh−18,750$2,302,264→ 62,811 total - Sale
Common shares without par value
2021-02-02$123.03/sh−3,130$385,084→ 59,681 total - Exercise/Conversion
Option (right to buy)
2021-02-01−18,750→ 18,750 totalExercise: $38.40From: 2019-02-19Exp: 2026-02-18→ Common Shares (18,750 underlying)
Footnotes (3)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $122.75 to $122.8250, inclusive. The reporting person undertakes to provide to Abbott Laboratories, any security holder of Abbott Laboratories, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $123.03 to $123.04, inclusive. The reporting person undertakes to provide to Abbott Laboratories, any security holder of Abbott Laboratories, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- [F3]Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.
Documents
Issuer
ABBOTT LABORATORIES
CIK 0000001800
Entity typeother
Related Parties
1- filerCIK 0001695686
Filing Metadata
- Form type
- 4
- Filed
- Feb 2, 7:00 PM ET
- Accepted
- Feb 3, 7:20 PM ET
- Size
- 10.9 KB